Distinct populations of highly potent TAU seed conformers in rapidly progressing Alzheimer’s disease

DNA sequencing with chain-terminating inhibitors

Sanger, F., Nicklen, S., & Coulson, A. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5463 · Cited by 68,572 · see citing works

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia

Rascovsky, K., Hodges, J. R., Knopman, D., Mendez, M. F., Kramer, J. H., Neuhaus, J., van Swieten, J. C., Seelaar, H., Dopper, E. G. P., Onyike, C. U., et al. (2011) · Brain · doi:10.1093/brain/awr179 · Cited by 5,221 · see citing works

National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

Hyman, B. T., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Carrillo, M. C., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., et al. (2012) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.10.007 · Cited by 3,092 · see citing works

National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

Montine, T. J., Phelps, C. H., Beach, T. G., Bigio, E. H., Cairns, N. J., Dickson, D. W., Duyckaerts, C., Frosch, M. P., Masliah, E., Mirra, S. S., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-011-0910-3 · Cited by 2,992 · see citing works

Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing

Alzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946 · see citing works

The Determinants of Quality of Life of Nursing Home Residents with Young-Onset Dementia and the Differences between Dementia Subtypes

Appelhof, B., Bakker, C., den IJssel, J. C. L. V. D., Zwijsen, S. A., Smalbrugge, M., Verhey, F. R. J., de Vugt, M. E., Zuidema, S. U., & Koopmans, R. T. C. M. (2017) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000477087 · Cited by 2,773 · see citing works

Eight prion strains have PrPSc molecules with different conformations

Safar, J., Wille, H., Itri, V., Groth, D., Serban, H., Torchia, M., Cohen, F. E., & Prusiner, S. B. (1998) · Nature Medicine · doi:10.1038/2654 · Cited by 1,244 · see citing works

[URE3] as an Altered URE2 Protein: Evidence for a Prion Analog in Saccharomyces cerevisiae

Wickner, R. B. (1994) · Science · doi:10.1126/science.7909170 · Cited by 1,216 · see citing works

Molecular structural basis for polymorphism in Alzheimer's β-amyloid fibrils

Paravastu, A. K., Leapman, R. D., Yau, W., & Tycko, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806270105 · Cited by 1,165 · see citing works

A General Model of Prion Strains and Their Pathogenicity

Collinge, J., & Clarke, A. R. (2007) · Science · doi:10.1126/science.1138718 · Cited by 1,058 · see citing works

Synthetic Mammalian Prions

Legname, G., Baskakov, I. V., Nguyen, H.-O. B., Riesner, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2004) · Science · doi:10.1126/science.1100195 · Cited by 1,022 · see citing works

Distinct Tau Prion Strains Propagate in Cells and Mice and Define Different Tauopathies

Sanders, D. W., Kaufman, S. K., DeVos, S. L., Sharma, A. M., Mirbaha, H., Li, A., Barker, S. J., Foley, A. C., Thorpe, J. R., Serpell, L. C., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.04.047 · Cited by 986 · see citing works

Exogenous α-synuclein fibrils seed the formation of Lewy body-like intracellular inclusions in cultured cells

Luk, K. C., Song, C., O’Brien, P., Stieber, A., Branch, J. R., Brunden, K. R., Trojanowski, J. Q., & Lee, V. M. ‐. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908005106 · Cited by 958 · see citing works

The National Alzheimer's Coordinating Center (NACC) Database: The Uniform Data Set

Beekly, D. L., Ramos, E. M., Lee, W. W., Deitrich, W. D., Jacka, M. E., Wu, J., Hubbard, J. L., Koepsell, T. D., Morris, J. C., & Kukull, W. A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e318142774e · Cited by 907 · see citing works

In Vitro Generation of Infectious Scrapie Prions

Castilla, J., Saá, P., Hetz, C. A., & Soto, C. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.011 · Cited by 790 · see citing works

Alzheimer's disease drug development pipeline: 2019

Cummings, J., Lee, G., Ritter, A., Sabbagh, M., & Zhong, K. (2019) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1016/j.trci.2019.05.008 · Cited by 762 · see citing works

Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules

Falcon, B., Zivanov, J., Zhang, W., Murzin, A. G., Garringer, H. J., Vidal, R., Crowther, R. A., Newell, K. L., Ghetti, B. F., Goedert, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1026-5 · Cited by 703 · see citing works

Tau PTM Profiles Identify Patient Heterogeneity and Stages of Alzheimer’s Disease

Wesseling, H., Mair, W., Kumar, M., Schlaffner, C. N., Tang, S., Beerepoot, P., Fatou, B., Guise, A. J., Cheng, L., Takeda, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.10.029 · Cited by 688 · see citing works

Early Clinical PET Imaging Results with the Novel PHF-Tau Radioligand [F18]-T808

Chien, D. T., Szardenings, A. K., Bahri, S., Walsh, J. C., Mu, F., Xia, C. A., Shankle, W. R., Lerner, A. J., Su, M., Elizarov, A. M., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130098 · Cited by 676 · see citing works

Generating a Prion with Bacterially Expressed Recombinant Prion Protein

Wang, F., Wang, X., Yuan, C., & Ma, J. (2010) · Science · doi:10.1126/science.1183748 · Cited by 659 · see citing works

Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes

Qiang, W., Yau, W., Lu, J., Collinge, J., & Tycko, R. (2017) · Nature · doi:10.1038/nature20814 · Cited by 634 · see citing works

Formation of native prions from minimal components in vitro

Deleault, N. R., Harris, B. T., Rees, J. R., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702662104 · Cited by 632 · see citing works

Self-Seeded Fibers Formed by Sup35, the Protein Determinant of [PSI+], a Heritable Prion-like Factor of S. cerevisiae

Glover, J. R., Kowal, A. S., Schirmer, E. C., Patino, M. M., Liu, J., & Lindquist, S. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80264-0 · Cited by 591 · see citing works

The physical basis of how prion conformations determine strain phenotypes

Tanaka, M., Collins, S. R., Toyama, B. H., & Weissman, J. S. (2006) · Nature · doi:10.1038/nature04922 · Cited by 589 · see citing works

Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer DiseasePreprint

Masters, C. L., & Selkoe, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006262 · Cited by 543 · see citing works

Critical role of acetylation in tau-mediated neurodegeneration and cognitive deficits

Min, S.-W., Chen, X., Tracy, T. E., Li, Y., Zhou, Y., Wang, C., Shirakawa, K., Minami, S. S., Defensor, E., Mok, S. A., et al. (2015) · Nature Medicine · doi:10.1038/nm.3951 · Cited by 516 · see citing works

Heparin-induced tau filaments are polymorphic and differ from those in Alzheimer’s and Pick’s diseases

Zhang, W., Falcon, B., Murzin, A. G., Fan, J., Crowther, R. A., Goedert, M., & Scheres, S. H. W. (2019) · eLife · doi:10.7554/elife.43584 · Cited by 500 · see citing works

Tau phosphorylation: physiological and pathological consequences

Stoothoff, W. H., & Johnson, G. V. W. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.06.017 · Cited by 439 · see citing works

Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease

Dujardin, S., Commins, C., Lathuiliere, A., Beerepoot, P., Fernandes, A. R., Kamath, T. V., De Los Santos, M. B., Klickstein, N., Corjuc, D. L., Corjuc, B. T., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0938-9 · Cited by 438 · see citing works

Darwinian Evolution of Prions in Cell Culture

Li, J., Browning, S. R., Mahal, S. P., Oelschlegel, A. M., & Weissmann, C. (2009) · Science · doi:10.1126/science.1183218 · Cited by 434 · see citing works

Global Hairpin Folding of Tau in Solution

Jeganathan, S., von Bergen, M., Brutlach, H., Steinhoff, H.-J., & Mandelkow, E. (2006) · Biochemistry · doi:10.1021/bi0521543 · Cited by 432 · see citing works

Rapid and ultra-sensitive quantitation of disease-associated α-synuclein seeds in brain and cerebrospinal fluid by αSyn RT-QuIC

Groveman, B. R., Orru, C. D., Hughson, A. G., Raymond, L. D., Zanusso, G., Ghetti, B. F., Campbell, K. J., Safar, J., Galasko, D. R., & Caughey, B. W. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0508-2 · Cited by 414 · see citing works

Sporadic human prion diseases: molecular insights and diagnosis

Puoti, G., Bizzi, A., Forloni, G., Safar, J., Tagliavini, F., & Gambetti, P. L. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70063-7 · Cited by 362 · see citing works

Tau filaments from multiple cases of sporadic and inherited Alzheimer's disease adopt a common fold

Falcon, B., Zhang, W., Schweighauser, M., Murzin, A. G., Vidal, R., Garringer, H. J., Ghetti, B., Scheres, S. H. W., & Goedert, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1914-z · Cited by 362 · see citing works

Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein

Atarashi, R., Moore, R. A., Sim, V. L., Hughson, A. G., Dorward, D. W., Onwubiko, H. A., Priola, S. A., & Caughey, B. W. (2007) · Nature Methods · doi:10.1038/nmeth1066 · Cited by 351 · see citing works

Genetic influence on the structural variations of the abnormal prion protein

Parchi, P., Zou, W., Wang, W., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.18.10168 · Cited by 330 · see citing works

Getting a Grip on Prions: Oligomers, Amyloids, and Pathological Membrane Interactions

Caughey, B. W., Baron, G. S., Chesebro, B. W., & Jeffrey, M. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.78.082907.145410 · Cited by 322 · see citing works

Rapidly progressive dementia

Geschwind, M. D., Shu, H., Haman, A., Sejvar, J. J., & Miller, B. L. (2008) · Annals of Neurology · doi:10.1002/ana.21430 · Cited by 320 · see citing works

A novel Alzheimer disease locus located near the gene encoding tau protein

Jun, G., Ibrahim-Verbaas, C. A., Vronskaya, M., Lambert, J.-C., Chung, J., Naj, A. C., Kunkle, B. W., Wang, L.-S., Bis, J. C., Bellenguez, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.23 · Cited by 297 · see citing works

The natively unfolded character of tau and its aggregation to Alzheimer-like paired helical filaments

Jeganathan, S., von Bergen, M., Mandelkow, E.-M., & Mandelkow, E. (2008) · Biochemistry · doi:10.1021/bi800783d · Cited by 286 · see citing works

Diagnosis of human prion disease

Safar, J., Geschwind, M. D., Deering, C., Didorenko, S., Sattavat, M., Sanchez, H. C., Serban, A. V., Vey, M., Baron, H., Giles, K., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409651102 · Cited by 274 · see citing works

Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer’s disease and PART

Kaufman, S. K., Del Tredici, K., Thomas, T. L., Braak, H., & Diamond, M. I. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1855-6 · Cited by 259 · see citing works

Molecular pathology of neurodegenerative diseases: principles and practice

Kovács, G. G. (2019) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2019-205952 · Cited by 243 · see citing works

Isolation of phosphatidylethanolamine as a solitary cofactor for prion formation in the absence of nucleic acids

Deleault, N. R., Piro, J. R., Walsh, D. J., Wang, F., Ma, J., Geoghegan, J. C., & Supattapone, S. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204498109 · Cited by 241 · see citing works

Measuring prions causing bovine spongiform encephalopathy or chronic wasting disease by immunoassays and transgenic mice

Safar, J., Scott, M., Monaghan, J., et al. (2002) · Nature Biotechnology · doi:10.1038/nbt748 · Cited by 240 · see citing works

Proteomic differences in amyloid plaques in rapidly progressive and sporadic Alzheimer’s disease

Drummond, E., Nayak, S., Faustin, A., Pires, G., Hickman, R. A., Askenazi, M., Cohen, M., Haldiman, T., Kim, C., Han, X., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1691-0 · Cited by 239 · see citing works

Diagnostic and prognostic value of human prion detection in cerebrospinal fluid

Foutz, A., Appleby, B. S., Hamlin, C. R., Liu, X., Yang, S., Cohen, Y., Chen, W., Blevins, J. E., Fausett, C. L., Wang, H., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24833 · Cited by 225 · see citing works

Inert and seed-competent tau monomers suggest structural origins of aggregation

Mirbaha, H., Chen, D., Morazova, O. A., Ruff, K. M., Sharma, A. M., Liu, X., Goodarzi, M., Pappu, R. V., Colby, D. W., Mirzaei, H., et al. (2018) · eLife · doi:10.7554/elife.36584 · Cited by 225 · see citing works

Mammalian Prions Generated from Bacterially Expressed Prion Protein in the Absence of Any Mammalian Cofactors

Kim, J.-I., Calì, I., Surewicz, K. A., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.113464 · Cited by 221 · see citing works

Pathological inclusion bodies in tauopathies contain distinct complements of tau with three or four microtubule‐binding repeat domains as demonstrated by new specific monoclonal antibodies

de Silva, R., Lashley, T., Gibb, G., Hanger, D. P., Hope, A., Reid, A. R., Bandopadhyay, R., Utton, M. A., Strand, C., Jowett, T. P., et al. (2003) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2003.00463.x · Cited by 220 · see citing works

β-Sheet Core of Tau Paired Helical Filaments Revealed by Solid-State NMR

Daebel, V., Chinnathambi, S., Biernat, J., Schwalbe, M., Habenstein, B., Loquet, A., Akoury, E., Tepper, K., Müller, H., Baldus, M., et al. (2012) · Journal of the American Chemical Society · doi:10.1021/ja305470p · Cited by 219 · see citing works

Continuum of prion protein structures enciphers a multitude of prion isolate-specified phenotypes

Legname, G., Nguyen, H.-O. B., Peretz, D., Cohen, F. E., DeArmond, S. J., & Prusiner, S. B. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608970103 · Cited by 219 · see citing works

Treatable neurological disorders misdiagnosed as Creutzfeldt‐Jakob disease

Chitravas, N., Jung, R. S., Kofskey, D., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22454 · Cited by 216 · see citing works

Chemical Kinetics for Bridging Molecular Mechanisms and Macroscopic Measurements of Amyloid Fibril Formation

Michaels, T. C. T., Šarić, A., Habchi, J., Chia, S., Meisl, G., Vendruscolo, M., Dobson, C. M., & Knowles, T. P. J. (2018) · Annual Review of Physical Chemistry · doi:10.1146/annurev-physchem-050317-021322 · Cited by 215 · see citing works

Prion Diseases and Their Biochemical Mechanisms

Cobb, N. J., & Surewicz, W. K. (2009) · Biochemistry · doi:10.1021/bi900108v · Cited by 212 · see citing works

Rapidly progressive Alzheimer’s disease features distinct structures of amyloid-β

Cohen, M. L., Kim, C., Haldiman, T., ElHag, M., Mehndiratta, P., Termsarasab, P., Lissemore, F. M., Shea, M., Cohen, Y., Chen, W., et al. (2015) · Brain · doi:10.1093/brain/awv006 · Cited by 202 · see citing works

Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease

Gallardo, G., & Holtzman, D. M. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-32-9358-8_16 · Cited by 201 · see citing works

Biochemical classification of tauopathies by immunoblot, protein sequence and mass spectrometric analyses of sarkosyl-insoluble and trypsin-resistant tau

Taniguchi-Watanabe, S., Arai, T., Kametani, F., Nonaka, T., Masuda-Suzukake, M., Tarutani, A., Murayama, S., Saito, Y., Arima, K., Yoshida, M., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-015-1503-3 · Cited by 200 · see citing works

Rapidly Progressive Alzheimer Disease

Schmidt, C., Wolff, M., Weitz, M., Bartlau, T., Korth, C., & Zerr, I. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.189 · Cited by 191 · see citing works

Cofactor molecules maintain infectious conformation and restrict strain properties in purified prions

Deleault, N. R., Walsh, D. J., Piro, J. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1206999109 · Cited by 187 · see citing works

The prion strain phenomenon: Molecular basis and unprecedented features

Morales, R., Abid, K., & Soto, C. A. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.12.006 · Cited by 170 · see citing works

Seeding selectivity and ultrasensitive detection of tau aggregate conformers of Alzheimer disease

Kraus, A., Saijo, E., Metrick, M. A., Newell, K., Sigurdson, C. J., Zanusso, G., Ghetti, B., & Caughey, B. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1947-3 · Cited by 143 · see citing works

Search for a Prion-Specific Nucleic Acid

Safar, J., Kellings, K., Serban, A. V., Groth, D., Cleaver, J. E., Prusiner, S. B., & Riesner, D. (2005) · Journal of Virology · doi:10.1128/jvi.79.16.10796-10806.2005 · Cited by 135 · see citing works

Aβ and tau prion-like activities decline with longevity in the Alzheimer’s disease human brain

Aoyagi, A., Condello, C., Stöhr, J., Yue, W., Rivera, B. M., Lee, J. C., Woerman, A. L., Halliday, G. M., van Duinen, S. G., Ingelsson, M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aat8462 · Cited by 130 · see citing works

De Novo Generation of Infectious Prions In Vitro Produces a New Disease Phenotype

Barria, M. A., Mukherjee, A., Gonzalez-Romero, D., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000421 · Cited by 127 · see citing works

Tau filaments in neurodegenerative diseases

Goedert, M. (2018) · FEBS Letters · doi:10.1002/1873-3468.13108 · Cited by 127 · see citing works

Acetylated Tau Neuropathology in Sporadic and Hereditary Tauopathies

Irwin, D. J., Cohen, T. J., Grossman, M., Arnold, S. E., McCarty-Wood, E., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2013) · The American Journal of Pathology · doi:10.1016/j.ajpath.2013.04.025 · Cited by 125 · see citing works

Prion clearance in bigenic mice

Safar, J., DeArmond, S. J., Kociuba, K., Deering, C., Didorenko, S., Bouzamondo, E., Prusiner, S. B., & Tremblay, P. (2005) · Journal of General Virology · doi:10.1099/vir.0.80947-0 · Cited by 120 · see citing works

Clinical Features of Rapidly Progressive Alzheimer’s Disease

Schmidt, C., Redyk, K., Meißner, B., Krack, L. A., von Ahsen, N., Roeber, S., Kretzschmar, H. A., & Zerr, I. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000278692 · Cited by 112 · see citing works

Variations in filament conformation dictate seeding barrier between three- and four-repeat Tau

Dinkel, P. D., Siddiqua, A., Huynh, H., Shah, M., & Margittai, M. (2011) · Biochemistry · doi:10.1021/bi2004685 · Cited by 104 · see citing works

New generation QuIC assays for prion seeding activity

Orru, C. D., Wilham, J. M., Vascellari, S., Hughson, A. G., & Caughey, B. W. (2012) · Prion · doi:10.4161/pri.19430 · Cited by 101 · see citing works

From tau phosphorylation to tau aggregation: what about neuronal death?

Buée, L., Troquier, L., Burnouf, S., Bélarbi, K., der Jeugd, A. V., Ahmed, T., Fernández-Gómez, F.-J., Caillierez, R., Grosjean, M., Bégard, S., et al. (2010) · Biochemical Society Transactions · doi:10.1042/bst0380967 · Cited by 99 · see citing works

Selective Precipitation of Prions by Polyoxometalate Complexes

Lee, I. S., Long, J. R., Prusiner, S. B., et al. (2005) · Journal of the American Chemical Society · doi:10.1021/ja055219y · Cited by 97 · see citing works

Prions and Protein Assemblies that Convey Biological Information in Health and Disease

Sanders, D. W., Kaufman, S. K., Holmes, B. B., & Diamond, M. I. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.026 · Cited by 90 · see citing works

Autoinduction of Protein Expression

Fox, B. G., & Blommel, P. G. (2009) · Current Protocols in Protein Science · doi:10.1002/0471140864.ps0523s56 · Cited by 87 · see citing works

Small Protease Sensitive Oligomers of PrPSc in Distinct Human Prions Determine Conversion Rate of PrPC

Kim, C., Haldiman, T., Surewicz, K. A., et al. (2012) · PLoS Pathogens · doi:10.1371/journal.ppat.1002835 · Cited by 84 · see citing works

Tau monomer encodes strains

Sharma, A. M., Thomas, T. L., Woodard, D. R., Kashmer, O. M., & Diamond, M. I. (2018) · eLife · doi:10.7554/elife.37813 · Cited by 80 · see citing works

Protease-Sensitive Conformers in Broad Spectrum of Distinct PrPSc Structures in Sporadic Creutzfeldt-Jakob Disease Are Indicator of Progression Rate

Kim, C., Haldiman, T., Cohen, Y., et al. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002242 · Cited by 79 · see citing works

Rapidly Progressive Alzheimer's Disease: A Multicenter Update

Schmidt, C., Haı̈k, S., Satoh, K., Rábano, A., Martínez‐Martín, P., Roeber, S., Brandel, J., Calero, M., de Pedro‐Cuesta, J., Laplanche, J., et al. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-120007 · Cited by 73 · see citing works

Prion disease tempo determined by host-dependent substrate reduction

Mays, C. E., Kim, C., Haldiman, T., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci72241 · Cited by 69 · see citing works

Degradation or aggregation: the ramifications of post-translational modifications on tau

Park, S., Lee, J. H., Jeon, J. H., & Lee, M. J. (2018) · BMB Reports · doi:10.5483/bmbrep.2018.51.6.077 · Cited by 68 · see citing works

Distinct prion-like strains of amyloid beta implicated in phenotypic diversity of Alzheimer's disease

Cohen, M. L., Appleby, B. S., & Safar, J. (2016) · Prion · doi:10.1080/19336896.2015.1123371 · Cited by 66 · see citing works

Sedimentation characteristics of the scrapie agent from murine spleen and brain

Prusiner, S. B., Hadlow, W. J., Eklund, C. M., et al. (1978) · Biochemistry · doi:10.1021/bi00616a020 · Cited by 64 · see citing works

Unfolding and aggregation during the thermal denaturation of streptokinase

Azuaga, A. I., Dobson, C. M., Mateo, P. L., et al. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03107.x · Cited by 62 · see citing works

Structural Determinants of Phenotypic Diversity and Replication Rate of Human Prions

Safar, J., Xiao, X., Kabir, M. E., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004832 · Cited by 59 · see citing works

Trans-Dominant Inhibition of Prion Propagation In Vitro Is Not Mediated by an Accessory Cofactor

Geoghegan, J. C., Miller, M. B., Kwak, A. H., Harris, B. T., & Supattapone, S. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000535 · Cited by 57 · see citing works

Highly Elevated Cerebrospinal Fluid Total Tau Level Reflects Higher Likelihood of Non-Amnestic Subtype of Alzheimer’s Disease

Pillai, J. A., Bonner‐Jackson, A., Bekris, L. M., Safar, J., Bena, J., & Leverenz, J. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190519 · Cited by 56 · see citing works

Acquisition of Drug Resistance and Dependence by Prions

Oelschlegel, A. M., & Weissmann, C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003158 · Cited by 55 · see citing works

A multifactorial model of pathology for age of onset heterogeneity in familial Alzheimer’s disease

Sepulveda-Falla, D., Chavez-Gutierrez, L., Portelius, E., Vélez, J. I., Dujardin, S., Barrera-Ocampo, A., Dinkel, F., Hagel, C., Puig, B., Mastronardi, C., et al. (2021) · Acta Neuropathologica · doi:10.1007/s00401-020-02249-0 · Cited by 54 · see citing works

Molecular pathogenesis of sporadic prion diseases in man

Safar, J. (2012) · Prion · doi:10.4161/pri.18666 · Cited by 53 · see citing works

Co-existence of Distinct Prion Types Enables Conformational Evolution of Human PrPSc by Competitive Selection

Haldiman, T., Kim, C., Cohen, Y., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.500108 · Cited by 53 · see citing works

Evolutional Aspects of Alzheimer's Disease Pathogenesis

Braak, H., & Tredici, K. D. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-129029 · Cited by 51 · see citing works

Human prions and plasma lipoproteins

Safar, J., Wille, H., Geschwind, M. D., Deering, C., Latawiec, D., Serban, A. V., King, D. J., Legname, G., Weisgraber, K. H., Mahley, R. W., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604021103 · Cited by 49 · see citing works

A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers

Noble, G. P., Wang, D. W., Walsh, D. J., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005017 · Cited by 47 · see citing works

Ultrastructural Studies on Scrapie Prion Protein Crystals Obtained from Reverse Micellar Solutions

Wille, H., & Prusiner, S. B. (1999) · Biophysical Journal · doi:10.1016/s0006-3495(99)77270-x · Cited by 45 · see citing works

Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrP Sc Species

Mays, C. E., van der Merwe, J., Kim, C., et al. (2015) · Journal of Virology · doi:10.1128/jvi.02142-15 · Cited by 44 · see citing works

Chapter 29 Molecular studies of prion diseases

Safar, J., & Prusiner, S. B. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)64030-3 · Cited by 43 · see citing works

Identification of Polypeptides in Neurofibrillary Tangles and Total Homogenates of Brains with Alzheimer's Disease by Tandem Mass Spectrometry

Minjarez, B. D., Rustarazo, M. L. V., del Pino, M. M. S., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121480 · Cited by 40 · see citing works

Artificial strain of human prions created in vitro

Kim, C., Xiao, X., Chen, S., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04584-z · Cited by 40 · see citing works

Alzheimer’s Disease: Genetic Polymorphisms and Rate of Decline

Schmidt, C., Wolff, M., von Ahsen, N., & Zerr, I. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000336790 · Cited by 39 · see citing works

Modeling the heterogeneity in risk of progression to Alzheimer's disease acrosscognitive profiles in mild cognitive impairment

Tatsuoka, C. M., Tseng, H., Jaeger, J., Váradi, F., Smith, M. A., Yamada, T., Smyth, K. A., Lerner, A. J., & Initiative, T. A. D. N. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt168 · Cited by 32 · see citing works

Rapidly Progressive Alzheimer’s Disease in Two Distinct Autopsy Cohorts

Pillai, J. A., Appleby, B. S., Safar, J., & Leverenz, J. B. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180155 · Cited by 32 · see citing works

Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions

Li, Q., Wang, F., Xiao, X., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005622 · Cited by 32 · see citing works

Pathologic tau conformer ensembles induce dynamic, liquid-liquid phase separation events at the nuclear envelope

Kang, S., Han, Z. Z., Daude, N., McNamara, E., Wohlgemuth, S. L., Molina‐Porcel, L., Safar, J., Mok, S., & Westaway, D. A. (2021) · BMC Biology · doi:10.1186/s12915-021-01132-y · Cited by 31 · see citing works

Diverse, evolving conformer populations drive distinct phenotypes in frontotemporal lobar degeneration caused by the same MAPT-P301L mutation

Daude, N., Kim, C., Kang, S., Eskandari‐Sedighi, G., Haldiman, T., Yang, J., Fleck, S. C., Gomez‐Cardona, E., Han, Z. Z., Borrego‐Écija, S., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02148-4 · Cited by 29 · see citing works

Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases

Kabir, M. E., & Safar, J. (2014) · Prion · doi:10.4161/pri.27661 · Cited by 16 · see citing works

CSF prion protein concentration and cognition in patients with Alzheimer disease

Schmidt, C., Artjomova, S., Hoeschel, M., & Zerr, I. (2013) · Prion · doi:10.4161/pri.23904 · Cited by 14 · see citing works

Structurally distinct external solvent-exposed domains drive replication of major human prions

Siddiqi, M. K., Kim, C., Haldiman, T., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009642 · Cited by 11 · see citing works

Pre-Progression Rates in Alzheimer's Disease Revisited

Schmidt, C., Karch, A., Artjomova, S., et al. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130074 · Cited by 8 · see citing works

Measurements of sedimentation coefficients

Steensgaard, J., Steven Humphries, & Spragg, S. P. (1992) · doi:10.1093/oso/9780199632084.003.0005 · Cited by 6 · see citing works

A Statistical Mechanical Deconvolution of the Differential Scanning Calorimetric Profiles of the Thermal Denaturation of Cyanomethemoglobin

Safarian, S., Alimohammadi, M., Saberi, A. A., et al. (2005) · The Protein Journal · doi:10.1007/s10930-005-7841-6 · Cited by 3 · see citing works

Molecular and Genetic Basis of Prion Diseases

Prusiner, S. B. (1998) · Humana Press eBooks · doi:10.1007/978-1-59259-726-0_102 · Cited by 1 · see citing works

All the Tau We Cannot See

Hyman, B. (2023) · Annual Review of Medicine · doi:10.1146/annurev-med-042921-023749 · Cited by 39 · see citing works

Effects of side chains in gas-phase amino acids: Conformational analysis and relative stabilities

Yang, G., Zhou, L., Zu, Y., et al. (2009) · Journal of Molecular Structure THEOCHEM · doi:10.1016/j.theochem.2009.01.006 · Cited by 7 · see citing works

Conformation and vibrational spectra of 1,2-diisocyanoethane

Schrumpf, G., & Martin, S. (1982) · Journal of Molecular Structure · doi:10.1016/0022-2860(82)85329-5 · Cited by 7 · see citing works

Relative energies, stereoelectronic interactions and conformational interconversions in silathiacyclohexanes

Freeman, F., Cha, C., Fang, C., et al. (2004) · Journal of Physical Organic Chemistry · doi:10.1002/poc.804 · Cited by 15 · see citing works

Exploring the temperature-dependent proportions of lidocaine conformers equilibria in supercritical carbon dioxide via NOESY

Khodov, I. A., Belov, K. V., Sobornova, V. V., et al. (2023) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2023.122620 · Cited by 14 · see citing works

Structural information from OH stretching vibrations—XVII. On the different conformers in benzylalcohols and anthracylmethanols

Visser, T., & van der Maas, J. H. (1986) · Spectrochimica Acta Part A Molecular Spectroscopy · doi:10.1016/0584-8539(86)80140-4 · Cited by 22 · see citing works